Home | Clinical Care | Research | Training | Division Activities

Education and Training:

B.S., SUNY at Buffalo; Buffalo, New York (1975)

M.D., SUNY at Stony Brook; Stony Brook, New York (1979)

Internship, Internal Medicine, New England Deaconess Hospital; Boston, MA, (1979-80)

Residency, Internal Medicine, New England Deaconess Hospital; Boston, Massachusetts (1980-82)

Fellowship, Division of Hematology, University of Washington; Seattle, Washington (1983-87)

Board Certified in Hematology
Terry Gernsheimer, M.D.
Professor of Medicine, Division of Hematology
University of Washington School of Medicine

Director of Medical Education, Puget Sound Blood Center
PSBC Director of Medical Transfusion Services, UWMC

Office Address:
Puget Sound Blood Center
Box 359190
921 Terry Avenue
Seattle, WA 98104

Phone:   (206) 292-6521
Fax:       (206) 343-5043
E-mail:   bldbuddy @u.washington.edu

 

CURRENT CLINICAL INTERESTS

Coagulation and thrombotic disorders; platelet disorders


CURRENT RESEARCH INTERESTS

Platelet transfusion and platelet immunology, autoimmune platelet disorders


SELECTED PUBLICATIONS

Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ:  Mechanisms of thrombocytopenia in autoimmune thrombocytopenic purpura: Evidence of both impaired platelet production and increased platelet clearance.  J. Clin. Invest. 80:33-40, 1987.

Stratton JR, Ballem PJ, Gernsheimer T, Cerqueira M, Slichter SJ:  Platelet destruction in autoimmune thrombocytopenic purpura: Quantitation of platelet kinetics and sites of clearance using Indium-111 labeled autologous platelets. J. Nucl. Med. 30:629-635, 1989.

Gernsheimer TB, Stratton J, Ballem PJ, Slichter SJ:  Mechanisms of treatment responses in autoimmune thrombocytopenic purpura (AITP).  N. Engl. J. Med. 320-974-980, 1989.

Reiner A, Gernsheimer T, Slichter SJ:  Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura. Blood 85:351-358, 1995.

Busch MP, Collier A, Gernsheimer T, Carrington JD, Flanigan TP, Kashkari M, Kennedy M, Kumar PN, Lane TA, Mellors JW, Mohandas K, Pollard RB, Viele M, Yomtovian R, Holland PV, McCurdy PR, and the VATS Study Group:  The viral activation transfusion study (VATS): Rationale, objectives, and design overview. Transfusion 36:854-859, 1996.

Trial to Reduce Alloimmunization to Platelets (TRAP) Trial Study Group [including Gernsheimer T].  A randomized trial evaluating leukocyte-reduction and UV-B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.  N. Eng. J. Med. 337:1861-1869, 1997.

Yomtovian R, Gernsheimer T, Assmann SF, Mohandas K, Lee T-H, Kalish LA, Busch MP:  WBC reduction in RBC concentrates by prestorage filtration: multicenter experience. Transfusion 41:1030-1036, 2001.

Collier AC, Kalish LA, Busch MP, Gernsheimer T:  Double-blind, randomized study of leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: results of the viral activation transfusion study.  JAMA 285:1592-1601, 2001.